(KCEN) -- Gen. Greg Abbott, the Texas Attorney General, said today that Texas and a coalition of 37 states have reached a deal with drug maker GlaxoSmithKline LLC in the enforcement action taken against them.
The company was accused of unlawfully promoting their diabetes drug, Avandia, and must pay $90 million to resolve these allegations. Texas will receive $6.2 million from the settlement.
According to the enforcement action the states held against the drug maker, GlaxoSmithKline misrepresented Avandia's cardiovascular risks and safety profile.
GlaxoSmithKline must pay the $90 million and must also reform the way it markets and promotes diabetes drugs. They must also post summaries of observational studies that inform providers of safe and appropriate uses of diabetes drugs and summaries of clinical trials.
These requirements will be in place for at least eight years.
